Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: A report from the Children's Oncology Group

Published:2014-01-22 Issue:6 Volume:61 Page:970-976
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Russell Heidi¹²,Swint J. Michael²³,Lal Lincy²,Meza Jane⁴,Walterhouse David⁵,Hawkins Douglas S.⁶,Okcu M. Fatih¹

Affiliation:

1. Texas Children's Cancer and Hematology Centers; Baylor College of Medicine; Houston Texas

2. University of Texas School of Public Health; Division of Management, Policy and Community Health; Houston Texas

3. University of Texas School of Medicine; Center for Clinical Research and Evidence-Based Medicine; Houston Texas

4. University of Nebraska Medical Center College of Public Health; University of Nebraska Medical Center; Omaha Nebraska

5. Ann & Robert H Lurie Children's Hospital of Chicago; Division of Hematology/Oncology/Stem Cell Transplant; Chicago Illinois

6. Seattle Children's Hospital, Fred Hutchinson Cancer Research Center; University of Washington, Department of Pediatrics; Seattle Washington

Funder

UTHealth Innovation Cancer Prevention Research Post-doctoral Fellowship, Cancer Prevention and Research Institute of Texas

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24950/fullpdf

Reference28 articles.

1. Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies;Malempati;Pediatr Blood Cancer,2012

2. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: The Children's Oncology Group;Meza;J Clin Oncol,2006

3. Results of the Intergroup Rhabdomyosarcoma Study Group 9602; protocol, using vincristine, and catinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group;Raney;J Clin Oncol,2011

4. Shorter duration therapy that includes vincristine (V), dactinomycin (A), and lower doses of cyclophosphamide (C) with or without radiation therapy for patients with newly diagnosed low-risk embryonal rhabdomyosarcoma (ERMS): A report from the Children's Oncology Group (COG);Walterhouse;J Clin Oncol (Meeting Abstracts),2011

5. Centers for Disease Control and Prevention. Clinical Growth Charts http://www.cdc.gov/growthcharts/clinical_charts.htm

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of the JRS-I LRA0401 and LRB0402 Japan Rhabdomyosarcoma Study Group trials for low-risk embryonal rhabdomyosarcoma;International Journal of Clinical Oncology;2024-08-23

2. LRA0401/ LRB0402 protocols for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma based on the central pathological review system: The first report from the Japan Rhabdomyosarcoma Study Group;2024-01-12

3. Rising drug cost impacts on cost‐effectiveness of 2 chemotherapy regimens for intermediate‐risk rhabdomyosarcoma: A report from the Children's Oncology Group;Cancer;2021-10-08

4. Asparaginase products in upfront acute lymphoblastic leukemia therapy: Value, location, and style;Pediatric Blood & Cancer;2018-10-14

5. Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232;Cancer Medicine;2017-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3